It began over a pint in a nondescript bar at an immunity and infectious disease conference in Lorne, a seaside town in Victoria, Australia. It was 2012 and Matt Cooper, a serial entrepreneur and a professor of chemical biology in the University of Queensland, was giving a talk to fellow scientists about antibiotics and superbugs. At the end of the talk he invited his audience to meet him in a nearby bar if they had any questions. In the audience was Luke O’Neill, a professor of biochemistry in Trinity College Dublin, who was also speaking at the conference. “Luke came…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .